Back to Search

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

Paper Details
Authors:
Kwaku Poku Asante
Daniel Ansong
Seyram Kaali
Samuel Adjei
Marc Lievens
Lydia Nana Badu
Prince Agyapong Darko
Patrick Boakye Yiadom Buabeng
Owusu Boahen
Theresa Rettig
Clara Agutu
Samuel Harrison
Yaw Ntiamoah
Japhet Adomako Anim
Elisha Adeniji
Albert Agordo Dornudo
Emilia Gvozdenović
David Dosoo
David Sambian
Harry Owusu-Boateng
Elvis Ato Wilson
Frank Prempeh
Pascale Vandoolaeghe
Lode Schuerman
Seth Owusu‐Agyei
Tsiri Agbenyega
Opokua Ofori‐Anyinam
Publication Date: 2020-03-17
Viral Infections and Outbreaks ResearchMedicineInfectious DiseasesHealth Sciences
Read Paper
External Resources
View on DOI

Paper information is provided by public research databases. Summaries are generated to aid understanding and may not reflect the complete scope of the work. For the authoritative version, please refer to the original publication.

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial - KNUST Research Atlas